Depot-specific regulation of autotaxin with obesity in human adipose tissue

Journal of Physiology and Biochemistry

Volumn 68, Issue 4, 2012, Pages 635-644

  Rancoule, Chloé ^a   Dusaulcy, Rodolphe ^a   Tréguer, Karine ^a   Grès, Sandra ^a   Guigné, Charlotte ^a   Quilliot, Didier ^b   Valet, Philippe ^a   Saulnier Blache, Jean Sébastien ^a  

^a University Hospital of Toulouse   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Adipose tissue; Autotaxin; Fat depots; Obesity

Indexed keywords

APELIN RECEPTOR; AUTOTAXIN; LEPTIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ADIPOSE TISSUE; ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; OBESITY; PROTEIN EXPRESSION; SUBCUTANEOUS FAT;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; OBESITY; ORGAN SPECIFICITY; PHOSPHORIC DIESTER HYDROLASES; SUBCUTANEOUS FAT; UP-REGULATION;

MUS;

EID: 84871291560     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-012-0181-z     Document Type: Article

References (23)

1. Achike FI, To NH, Wang H, Kwan CY (2011) Obesity, metabolic syndrome, adipocytes and vascular function: a holistic viewpoint. Clin Exp Pharmacol Physiol 38:1- 10
2. Boucher J, Quilliot D, Praderes JP, Simon MF, Gres S, Guigne C, Prevot D, Ferry G, Boutin JA, Carpene C, Valet P, Saulnier-Blache JS (2005) Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia 48:569-577
3. Boutin JA, Ferry G (2009) Autotaxin. Cell Mol Life Sci 66:3009-3021
4. Dusaulcy R, Rancoule C, Gres S, Wanecq E, Colom A, Guigne C, van Meeteren LA, Moolenaar WH, Valet P, Saulnier-Blache JS (2011) Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J Lipid Res 52:1247- 1255
5. Ferry G, Moulharat N, Pradere JP, Desos P, Try A, Genton A, Giganti A, Beucher-Gaudin M, Lonchampt M, Bertrand M, Saulnier-Blache JS, Tucker GC, Cordi A, Boutin JA (2008) S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool. J Pharmacol Exp Ther 327:809-819
6. Ferry G, Tellier E, Try A, Gres S, Naime I, Simon MF, Rodriguez M, Boucher J, Tack I, Gesta S, Chomarat P, Dieu M, Raes M, Galizzi JP, Valet P, Boutin JA, Saulnier-Blache JS (2003) Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem 278:18162-18169
7. Fotopoulou S, Oikonomou N, Grigorieva E, Nikitopoulou I, Paparountas T, Thanassopoulou A, Zhao Z, Xu Y, Kontoyiannis DL, Remboutsika E, Aidinis V (2010) ATX expression and LPA signalling are vital for the development of the nervous system. Dev Biol 339:451- 464
8. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
9. Gesta S, Simon MF, Rey A, Sibrac D, Girard A, Lafontan M, Valet P, Saulnier-Blache JS (2002) Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis. J Lipid Res 43:904-910
10. Jeon ES, Moon HJ, Lee MJ, Song HY, Kim YM, Cho M, Suh DS, Yoon MS, Chang CL, Jung JS, Kim JH (2008) Cancerderived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 26:789-797
11. Lau TT, Wang DA (2010) Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther 11:189-197
12. Liu S, Murph M, Panupinthu N, Mills GB (2009) ATX-LPA receptor axis in inflammation and cancer. Cell Cycle 8:3695-3701
13. Pradere JP, Tarnus E, Gres S, Valet P, Saulnier-Blache JS (2007) Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase. Biochim Biophys Acta 1771:93-102
14. Rancoule C, Pradere JP, Gonzalez J, Klein J, Valet P, Bascands JL, Schanstra JP, Saulnier-Blache JS (2011) Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opin Investig Drugs 20:657-667
15. Simon MF, Daviaud D, Pradere JP, Gres S, Guigne C, Wabitsch M, Chun J, Valet P, Saulnier-Blache JS (2005) Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent downregulation of peroxisome proliferator-activated receptor gamma2. J Biol Chem 280:14656-14662
16. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, Noji S, Yatomi Y, Aoki J, Arai H (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281:25822- 25830
17. Tokumura A, Kume T, Fukuzawa K, Tsukatani H (1981) Cardiovascular effects of lysophosphatidic acid and its structural analogs in rats. J Pharmacol Exp Ther 219:219- 224
18. van Meeteren LA, Moolenaar WH (2007) Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46:145-160
19. van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, Pettit TR, Wakelam MJ, Saulnier- Blache JS, Mummery CL, Moolenaar WH, Jonkers J (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26:5015-5022
20. Xu YJ, Aziz OA, Bhugra P, Arneja AS, Mendis MR, Dhalla NS (2003) Potential role of lysophosphatidic acid in hypertension and atherosclerosis. Can J Cardiol 19:1525-1536
21. Xu YJ, Rathi SS, Zhang M, Bhugra P, Dhalla NS (2002) Mechanism of the positive inotropic effect of lysophosphatidic acid in rat heart. J Cardiovasc Pharmacol Ther 7:109-115
22. Yuelling LM, Fuss B (2008) Autotaxin (ATX): a multifunctional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties. Biochim Biophys Acta 1781:525-530
23. Zhou Z, Subramanian P, Sevilmis G, Globke B, Soehnlein O, Karshovska E, Megens R, Heyll K, Chun J, Saulnier- Blache JS, Reinholz M, van Zandvoort M, Weber C, Schober A (2011) Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab 13:592-600